Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Interest Expense

The Interest Expense of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 15, 2026 is -28.17 M CNY. In the previous year, Interest Expense was -21.86 M CNY — a change of 28.86% (lower).

Interest Expense

-28.17 MCNY

YoY

28.86%

Last updated:

Interest Expense of Vcanbio Cell & Gene Engineering Corp is 2024 -28.17 M CNY. Interest Expense of Vcanbio Cell & Gene Engineering Corp was 2023 -21.86 M CNY. It decreases by 28.86% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-63.60 M CNY
Jan 1, 2018
89.30 M CNY
Jan 1, 2019
-31.70 M CNY
Jan 1, 2020
-1.80 M CNY
Jan 1, 2021
92.07 M CNY
Jan 1, 2022
1.32 M CNY
Jan 1, 2023
-21.86 M CNY
Jan 1, 2024
-28.17 M CNY
The Vcanbio Cell & Gene Engineering Corp Interest Expense history
YEARInterest ExpenseYoY
-28.17 MCNY+28.86%
-21.86 MCNY-1,759.26%
1.32 MCNY-98.57%
92.07 MCNY-5,214.91%
-1.80 MCNY-94.32%
-31.70 MCNY-135.50%
89.30 MCNY-240.41%
-63.60 MCNY+127.96%
-27.90 MCNY-118.65%
149.60 MCNY+3,224.44%
4.50 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Interest Expense of Vcanbio Cell & Gene Engineering Corp is -28.17 M CNY in 2024.

Interest Expense of Vcanbio Cell & Gene Engineering Corp changed from -21.86 M CNY to -28.17 M CNY, representing a 28.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vcanbio Cell & Gene Engineering Corp

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vcanbio Cell & Gene Engineering Corp